Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Cirrhosis Liver'
Cirrhosis Liver published presentations and documents on DocSlides.
Decompensated cirrhosis Clinical Practice Guidelines
by kittie-lecroy
About these slides. These slides give a comprehen...
MM: HCV and Cirrhosis Patient Case
by devin732
Chris Kolkman. PrimaryOne. Health. Meet MM. Patie...
Treatment regimens
by natalia-silvester
Co-formulated . ombitasvir. (OBV)/. paritaprevir...
C-SALT Study:
by marina-yarberry
grazoprevir. . + . elbasvir. . in genotype 1 wi...
Treatment regimens
by mitsue-stanley
Co-formulated . ombitasvir. (OBV)/. paritaprevir...
Ledipasvir-Sofosbuvir in Treatment-Experienced GT1 with Cir
by pamella-moone
SIRIUS. Phase . 2 . Treatment. . Experienced. Bo...
No randomisation
by tatiana-dople
N = 100. W12. W24. Arm B: . compensated cirrhosis...
C-SWIFT Study: elbasvir/grazoprevir + SOF
by pamella-moone
in genotypes 1 or 3, with or without cirrhosis. &...
C-SWIFT Study: elbasvir/grazoprevir + SOF
by myesha-ticknor
in genotypes 1 or 3, with or without cirrhosis. &...
Not randomised Open-label
by cheryl-pisano
18-70 years. HCV genotype 1 or 3. Naïve or failu...
Simplified HCV Therapy in 2018
by phoebe-click
This program is s. upported. by educational gran...
Efficacy and Safety of
by olivia-moreira
Efficacy and Safety of Glecaprevir / Pibrentasvi...
INVESTOR FACT SHEET
by kittie-lecroy
INVESTOR FACT SHEET October 2011 Lipocine Inc. F...
Mazen Hassanain Portal Hypertension
by escapistlego
Causes. Cirrhosis. Non-cirrhosis. Symptoms. Asympt...
Management of Alcoholic Hepatitis
by friendma
and Cirrhosis. W. Ray Kim, MD. Gastroenterology an...
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
by della
Kristen M. Marks, MD. Assistant Professor. Weill C...
ST Hepatitis C Support Project Written by Alan Franciscus EditorinChief What is Cirrhosis HCSP FACT SHEET A publication of the Hepatitis C Support Project The information in this fact sheet is desi
by pamella-moone
ST 57513 2014 Hepatitis C Support Project Written ...
Cirrhosis National Digestive Diseases Information Clea
by karlyn-bohler
Scar tissue replaces healthy liver tissue and par...
Daclatasvir
by tatyana-admore
. + . Sofosbuvir. in Genotype . 3. ALLY-3 Study...
Primary Biliary Cirrhosis Name Change InitiativePart 1Supported by the
by mitsue-stanley
said this couldnt happen at a better t...
Hepatitis B Case Studies
by yoshiko-marsland
Nina Kim, MD MSc. Associate Professor of Medicine...
SIRIUS
by tawny-fly
Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...
Randomisation
by pamella-moone
*. 1:1. Open-label. ≥ 18 years. HCV genotype ...
SOF/VEL
by trish-goza
400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...
B. Taskin, Bern 12.08.2015
by mitsue-stanley
Liver. Imaging Reporting . and. Data System . w...
LIVERFAILURE/CIRRHOSIS/PORTALHYPERTENSION
by trish-goza
ContinuationofMetforminUseAfteraDiagnosisof Cirrho...
Sofosbuvir-Velpatasvir
by jane-oiler
(. Epclusa. ). Prepared by. : H. Nina Kim, MD MS...
60% of lean body weight = water
by danika-pritchard
(2/3) intracellular. . (1/3)ext...
Hepatitis B Case Studies
by alida-meadow
Nina Kim, MD MSc. Associate Professor of Medicine...
No randomisation
by pamella-moone
Open-label. 18-70 years. HCV genotype 1. Naïve o...
Gynecomastia
by pamella-moone
. Dr. . Ayed. . Alanezi. Senior . spescialist....
C-WORTHY/B
by stefany-barnette
Randomisation*. Open-label. >. 18 years. HCV ...
SOF + RBV
by debby-jeon
SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....
Two parallel arms
by test
Open label. ≥ . 18 years, . HCV genotype 1 to ...
Sofosbuvir-Velpatasvir in Genotype 2
by stefany-barnette
ASTRAL-2*. Phase 3. . Treatment. . Naïve &...
≥ 18 years HCV genotype 1, 2, 4, 5, 6
by alexa-scheidler
HCV RNA ≥ 1000 IU/mL. Treatment-naïve or treat...
Chronic hepatitis C: guidelines for screening and
by aaron
treatment. Lisa M. Glass, MD. Clinical Lecturer. ...
Hepatocellular carcinoma in West Africa:
by tatyana-admore
risk factors and pathogenesis. Dr Richard Phillip...
AHCCCS Pharmacy and Therapeutics Committee
by debby-jeon
August 16, 2016. 5-17-16 Minutes. Review and vote...
Approach to Ascites Updated by Daniel Kim, 06/2017
by tatyana-admore
Objectives. Become familiar with the different et...
Load More...